… toxicities encountered in head and neck cancer will also allow the rational development of
toxicity … New methods are needed to summarize the global or aggregate toxicity of a treatment …

… Vanderbilt Ingram Cancer Center, Nashville, Tennessee … facing head and neck cancer
patients who present with metastatic or locally recurrent head and neck cancer; such as, limited …

… : ‘head and neck cancer’, ‘IMRT’, ‘outcomes’ and ‘toxicity’. The … Articles in English reporting
on adult head and neck cancer … one measure of late toxicity and survival outcomes (LRC, …

… to obtain patient-reported outcomes of head and neck cancer survivors through an Internet-…
For this group dysphagia and dermatitis were the most commonly reported toxicities, as was …

… outcomes. Paclitaxel has now been delivered concurrently with RT for patients with head-and-neck
cancer in a variety of schedules alone and combined with other agents 23, 24. …

… In recent decades, outcomes of patients with head and neck cancer (HNC) have improved
… of increased toxicity. One way to reduce radiation-related toxicity is by reducing the margins. …

… definitive treatment of advanced head and neck carcinomas. In addition, we report our
initial clinical outcomes, including locoregional and distant control as well as disease-free and …

… -neck cancer patients who were enrolled in a larger study [23] evaluating the clinical significance
of ePROs during RT at a National Cancer Institute—designated comprehensive cancer …

… acute toxicity. The purpose of the current study is to report the long-term clinical outcome
and toxicity of using SBRT as a boost treatment for locally advanced head and neck cancer. …

… toxicity burden, in head and neck cancer (HNC) patients. We aimed to develop and externally
validate NTCP models for various toxicities … lists all toxicity outcomes and the toxicity items …